Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (49.6%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (37.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (4.9%), Switzerland (1.2%), Europe/Middle East/Africa (22.4%), the United States (30.9%), North America (3.7%), China (8.4%), Asia/Pacific (10.2%), Brazil (10.5%) and Latin America (7.8%).
- agrochemicals (49.6%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (37.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (4.9%), Switzerland (1.2%), Europe/Middle East/Africa (22.4%), the United States (30.9%), North America (3.7%), China (8.4%), Asia/Pacific (10.2%), Brazil (10.5%) and Latin America (7.8%).
Source: Cofisem - Last Update: 2023-05-11
Key Executives
| Chairman of the Management Board | |
| Member of the Management Board | |
| Member of the Management Board | |
| Member of the Management Board | |
| Member of the Management Board | |
| Member of the Management Board | |
| Chief Financial Officer | |
| Human Resources Director | |
| Investor Relations Director | |
| VP, Communication |
Source: Cofisem - Last Update: 2023-03-03
Key Figures
| Millenium | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Net sales | 50,739,000 | 44,081,000 | 41,400,000 | 43,545,000 | 39,586,000 |
| Income from ordinary activities | 50,739,000 | 44,081,000 | 41,400,000 | 43,545,000 | 39,586,000 |
| Operating income | 7,012,000 | 3,353,000 | -16,169,000 | 4,162,000 | 3,914,000 |
| Cost of financial indebtedness net | 1,058,000 | 930,000 | 1,292,000 | 1,281,000 | 1,065,000 |
| Equity-accounted companies contribution to income | -150,000 | 49,000 | -96,000 | 68,000 | |
| Net profit from discontinued activities | 5,074,000 | ||||
| Net income | 4,166,000 | 1,022,000 | -10,487,000 | 4,110,000 | 1,711,000 |
| Net income (Group share) | 4,150,000 | 1,000,000 | -10,495,000 | 4,091,000 | 1,695,000 |
| Fiscal year end | 12.22 | 12.21 | 12.2 | 12.19 | 12.18 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
| Account Standards |
Source: Cofisem - Last Update: 2023-05-11
Shareholder information
Source: Cofisem - Last Update: 2023-05-11
Address
Bayer AG
Kaiser-Wilhelm Allee 1
DE-51368 Leverkusen, Nordrhein-Westfalen
Germany
Phone number: +49 214 30 1
https://www.bayer.com/
Source: Cofisem - Last Update: 2023-05-11
Please contact MyQuestion.Italy@euronext.com for Company Profile support.